[Use of inhibitors of glutathione and glutathione transferase for overcoming resistance of tumor to cytostatics in an in vivo system].
Donenko
F V
FV
Sitdikova
S M
SM
Kabieva
A O
AO
Polotskiĭ
B E
BE
Machaladze
Z O
ZO
Davydov
M I
MI
Moroz
L V
LV
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D019328:Buthionine Sulfoximine; D004317:Doxorubicin / Q000627:therapeutic use; D004351:Drug Resistance; D005978:Glutathione / Q000037:antagonists & inhibitors*; D005982:Glutathione Transferase / Q000037:antagonists & inhibitors*; D007941:Leukemia P388 / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008717:Methionine Sulfoximine / Q000031:analogs & derivatives / Q000627:therapeutic use; D051379:Mice; D014407:Tumor Cells, Cultured
D000964:Antimetabolites, Antineoplastic; D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D004317:Doxorubicin; D005982:Glutathione Transferase; D005978:Glutathione
Primenenie ingibitorov glutationa i glutationtransferaz dlia preodoleniia rezistentnosti opukholeĭ k tsitostatikam v sistem in vivo.